The drugmakers previously projected making about 2.5 billion doses this year. By mid-April, Pfizer said it had signed contracts accounting for 1.6 billion doses to be delivered this year, according to The Hill.
The vaccine earned Pfizer $3.5 billion in the first quarter of 2020, the company said May 4.
Read the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
